Greenbrook

Mclean, United States

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

$1.2M raised

Feb 2024

Post-IPO Equity

Health Care Medical Neuroscience Psychology Therapeutics

Top Investors

Madryn Asset Management Oxford Finance LLC Alumni Capital Management Greybrook Realty Partners Masters Special Situations

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Greenbrook

How much funding has Greenbrook raised?

Greenbrook has raised $1.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.

Who are Greenbrook's investors?

Greenbrook's investors include Madryn Asset Management, Oxford Finance LLC, Alumni Capital Management, Greybrook Realty Partners, Masters Special Situations.

Where is Greenbrook headquartered?

Greenbrook is headquartered in Mclean, United States.

What does Greenbrook do?

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

What stage is Greenbrook at?

Greenbrook is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 22, 2024.

MLA

"Greenbrook — Funding & Investors." VCBacked, February 22, 2024, https://www.vcbacked.co/company/greenbrook. Accessed July 2, 2026.

APA

VCBacked. (2024). Greenbrook — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/greenbrook

Wikipedia (cite web)

{{cite web |title=Greenbrook — Funding & Investors |url=https://www.vcbacked.co/company/greenbrook |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 22, 2024.

Similar Companies in Health Care

Allterum Therapeutics